PharVision Advisers’s Boeing BA Stock Holding History

PharVision Advisers’s Portfolio BA Stock Details BA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,509	Closed	-$326K	–	705
2025 Q3	$326K	Buy	+1,509	New	+$340K	0.18%	180

Other funds holding BA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's BA Position: Q4 2025 in Review

PharVision Advisers sold out of Boeing (BA) in Q4 2025, closing a stake of 1,509 shares — an estimated $326K sold.

PharVision Advisers first reported a position in BA in Q3 2025 and held it in 1 quarter. The position peaked at $326K in Q3 2025. 2,529 funds tracked by Wall St. Rank hold BA as of Q4 2025.

PharVision Advisers reported no remaining Boeing position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,509 Boeing shares in Q4 2025, an estimated $326K.
PharVision Advisers first reported a position in Boeing in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Boeing position peaked at $326K in Q3 2025.
2,529 funds tracked by Wall St. Rank held Boeing as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.